Volume 3, Number 6 (December 1997)

Guest Editorial

The ins and outs of antiviral drug transport in the brain.
Gallo JM.
pp. 385-386


The entry of antiviral and antiretroviral drugs into the central nervous system
Groothuis DR, Levy RM.
pp. 387-400

An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis
Persidsky Y, Buttini M, Limoges J, Bock P, Gendelman HE.
pp. 401-416

Pathogenesis of ovine lentiviral encephalitis: derivation of a neurovirulent strain by in vivo passage
Craig LE, Sheffer D, Meyer AL, Hauer D, Lechner F, Peterhans E, Adams RJ, Clements JE, Narayan O, ZinkMC.
pp. 417-427

Role of virus receptor-bearing endothelial cells of the blood-brain barrier in preventing the spread of mousehepatitis virus-A59 into the central nervous system
Godfraind C, Havaux N, Holmes KV, Coutelier JP.
pp. 428-434

A 65-kDa trypsin-sensible membrane cell protein as a possible receptor for dengue virus in cultured neuroblastoma cells
Ramos-Castaneda J, Imbert JL, Barron BL, Ramos C.
pp. 435-440

Neuronal reactivation of herpes simplex virus may involve interleukin-6
Kriesel JD, Ricigliano J, Spruance SL, Garza HH Jr, Hill JM.
pp. 441-448

Short Communications

Transient infection of astrocytes with HIV-1 primary isolates derived from patients with and without AIDS dementia complex
Brengel-Pesce K, Innocenti-Francillard P, Morand P, Chanzy B, Seigneurin JM.
pp. 449-454

C2H2-546: a zinc finger protein differentially expressed in HTLV-1 infected T cells
Drew PD, Gado AM, Canning RD, Nagle JW, Dehejia AM, Polymeropoulos MH, Biddison WE, Jacobson S, Becker KG.
pp. 455-459

Case Report

Severe neurological complications in association with Epstein-Barr virus infection
Corssmit EP, Leverstein-van Hall MA, Portegies P, Bakker P.
pp. 460-464